Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Ra Pharmaceuticals, Inc.Listing unverified | Other | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | Other | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | Sell | $5.7K | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | Buy | $4.4M | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | Other | $5.6K | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | Other | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Ra Pharmaceuticals, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Sorrento Tech, Inc.Listing unverified | BuyD (derivative) | — | SEC | |
Sorrento Tech, Inc.Listing unverified | BuyD (derivative) | — | SEC | |
Sorrento Tech, Inc.Listing unverified | BuyD (derivative) | — | SEC | |
INTERLEUKIN GENETICS INCListing unverified | Buy | $2M | SEC | |
INTERLEUKIN GENETICS INCListing unverified | BuyD (derivative) | — | SEC | |
ARDELYX, INC.Listing on record | Buy | $6.7M | SEC | |
ARDELYX, INC.Listing on record | Buy | $6.7M | SEC | |
TESARO, Inc.Listing unverified | Buy | $25M | SEC | |
TESARO, Inc.Listing unverified | Buy | $25M | SEC | |
ARDELYX, INC.Listing on record | Buy | $5M | SEC | |
ARDELYX, INC.Listing on record | Buy | $5M | SEC | |
Epizyme, Inc.Listing unverified | Buy | $10M | SEC | |
Avalo Therapeutics, Inc.Listing on record | Other | — | SEC | |
Avalo Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC | |
SYNLOGIC, INC.Listing on record | OtherD (derivative) | — | SEC |